Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ye-Jee Kim"'
Autor:
Hyesoo Cho1, Ye-Jee Kim, Ik Jun Moon1, Woo Jin Lee1, Chong Hyun Won1, Mi Woo Lee1, Sung Eun Chang1 changse2016@gmail.com, Joon Min Jung1 bban29@hanmail.net
Publikováno v:
Journal of Dermatological Treatment. Dec2024, Vol. 35 Issue 1, p1-8. 8p.
Publikováno v:
American Journal of Gastroenterology (Lippincott Williams & Wilkins). Jan2024, Vol. 119 Issue 1, p127-137. 11p.
Autor:
Ga Hee Kim, Hyungchul Park, Kee Wook Jung, Min-Ju Kim, Ye-Jee Kim, Ji Min Lee, Bong Eun Lee, Yang Won Min, Jeong Hwan Kim, Hee Kyong Na, Ji Yong Ahn, Jeong Hoon Lee, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung, Hyun Jin Kim
Publikováno v:
Gut & Liver; Nov2023, Vol. 17 Issue 6, p894-904, 11p
Autor:
Joong-Yeol Park, Hwi Seung Kim, Jiwoo Lee, Woo Je Lee, Ye-Jee Kim, Yun Kyung Cho, Chang Hee Jung
Publikováno v:
Aging (Albany NY)
We evaluated the association of metabolic health and obesity phenotypes with the risk of Alzheimer's disease (AD). This study enrolled 136,847 elderly participants aged 60 or above from the Korean National Health Insurance System. At baseline examina
Autor:
Eun-Ho Lee, Kyoung-Woon Joung, Sang-wook Lee, Jeong-Hyun Choi, Min-Ju Kim, Ye-Jee Kim, Jae-Sik Nam, In-Cheol Choi
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 4612, p 4612 (2021)
Journal of Clinical Medicine
Volume 10
Issue 19
Journal of Clinical Medicine
Volume 10
Issue 19
Adequate preoperative evaluation of frailty can greatly assist in the efficient allocation of hospital resources and planning treatments. However, most of the previous frailty evaluation methods, which are complicated, time-consuming, and can have in
Publikováno v:
Frontiers in Endocrinology; 10/20/2022, Vol. 13, p01-09, 9p
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Scientific Reports
The effect of body mass index (BMI) changes and variability on the risk for Alzheimer’s disease (AD) remains unclear. We analyzed 45,076 participants, whose BMI were measured on phase 1 (2002–2003), phase 2 (2004–2005), and phase 3 (2006–2007
Publikováno v:
Journal of Obesity & Metabolic Syndrome; Jun2022, Vol. 31 Issue 2, p178-186, 9p
Publikováno v:
Journal of Preventive Medicine and Public Health
Journal of Preventive Medicine and Public Health, Vol 51, Iss 1, Pp 15-22 (2018)
Journal of Preventive Medicine and Public Health, Vol 51, Iss 1, Pp 15-22 (2018)
Objectives The use of administrative data is an affordable alternative to conducting a difficult large-scale medical-record review to estimate the scale of adverse events. We identified adverse events from 2002 to 2013 on the national level in Korea,
Publikováno v:
Signa Vitae. Jan2023, Vol. 19 Issue 1, p43-49. 7p.